Cipla subsidiary recalls a consignment of medicines in the US due to improper sealing of packets
[ad_1]
pattern photo
X @Cipla_Global
Due to the seal breaking, the powder started spilling out of the packet. It was said that if the seal of the packet is not closed properly, there is a fear of powder falling from inside it, which will reduce its weight. Cipla said that primarily newborns and young children may be affected by this.
New Delhi. A subsidiary of pharmaceutical major Cipla has recalled one of its consignments in the US due to the fact that the packets were not sealed properly. The company gave this information on Sunday. Invagen Pharmaceuticals in the US is recalling a batch of ‘Vigabatrin for oral solution, USP (500 mg)’ at the consumer level following a case of improper sealing of the drug, the Mumbai-headquartered drug company said.
Due to the seal breaking, the powder started spilling out of the packet. It was said that if the seal of the packet is not closed properly, there is a fear of powder falling from inside it, which will reduce its weight. Cipla said that primarily newborns and young children may be affected by this. If the medicine is reduced and these people do not get the medicine in appropriate quantity then adverse effects may occur.
Disclaimer: IndiaTheNews has not edited this news. This news has been published from PTI-language feed.
other news
[ad_2]
Source link
